Treatment of alzheimer's disease

Aisen, 2000, A randomized controlled trial of prednisone in Alzheimer's disease, Neurology, 54, 588, 10.1212/WNL.54.3.588 Anthony, 2000, Reduced prevalence of AD in users of NSAIDs and H2 receptor antagonists, Neurology, 54, 2066, 10.1212/WNL.54.11.2066 Broe, 2000, Antiinflammatory drugs protect against Alzheimer's disease at low doses, Arch Neurol, 57, 1586, 10.1001/archneur.57.11.1586 Burns, 1999, The effects of donepezil in Alzheimer's disease—results from a multinational trial, Dementia Geriatr Cogn Disord, 10, 237, 10.1159/000017126 Corey-Bloom, 1998, A randomized trial evaluating the efficacy and safety of ENA 713 (rivastigmine tartrate), a new acetylcholinesterase inhibitor, in patients with mild to moderately severe Alzheimer's disease, Int J Geriatr Psychopharmacol, 1, 55 Cummings, 2000, Cholinesterase inhibitors: anew class of psychotropic agents, Am J Psychiatry, 157, 4, 10.1176/ajp.157.1.4 Davis, 1992, A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease, N Engl J Med, 327, 1253, 10.1056/NEJM199210293271801 Emilien, 2000, Prospects for pharmacological intervention in Alzheimer's disease, Arch Neurol, 57, 454, 10.1001/archneur.57.4.454 Farlow, 1992, a controlled trial of tacrine in Alzheimer's disease, JAMA, 268, 2523, 10.1001/jama.1992.03490180055026 Francis, 1999, The cholinergic hypothesis of Alzheimer's disease: a review of progress, J Neurol Neurosurg Psychiatry, 66, 137, 10.1136/jnnp.66.2.137 Henderson, 2000, Estrogen for Alzheimer's disease in women: randomized, double-blind, placebo-controlled trial, Neurology, 54, 295, 10.1212/WNL.54.2.295 Kawas, 1997, A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: The Baltimore Longitudinal Study of Aging, Neurology, 48, 1517, 10.1212/WNL.48.6.1517 Knapp, 1994, A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease, JAMA, 271, 985, 10.1001/jama.1994.03510370037029 Lyketsos, 2000, Randomized, placebo-controlled, double-blind clinical trial of sertraline in the treatment of depression complicating Alzheimer's disease: initial results from the Depression in Alzheimer's Disease Study, Am J Psychiatry, 157, 1686, 10.1176/appi.ajp.157.10.1686 Mayeux, 1999, Treatment of Alzheimer's disease, N Engl J Med, 34, 1670, 10.1056/NEJM199911253412207 McKeith, 2000, Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study, Lancet, 356, 2031, 10.1016/S0140-6736(00)03399-7 Mega, 1999, The spectrum of behavioral responses to cholinesterase inhibitor therapy in Alzheimer's disease, Arch Neurol, 56, 1388, 10.1001/archneur.56.11.1388 Mendez, 1999, Use of donepezil for vascular dementia: preliminary clinical experience, J Neuropsychiatry Clin Neurosci, 11, 268, 10.1176/jnp.11.2.268 Mulnard, 2000, Estrogen replacement therapy for treatment of mild to moderate Alzheimer's disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study, JAMA, 283, 1007, 10.1001/jama.283.8.1007 Raskind, 2000, Galantamine in AD: a 6-month randomized, placebo-controlled trial with a 6-month extension, Neurology, 54, 2261, 10.1212/WNL.54.12.2261 Rogers, 1998, A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease, Neurology., 50, 136, 10.1212/WNL.50.1.136 Rogers, 1998, Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: an interim analysis of the results of a US multicenter open label extension study, Eur Neuropsychopharmacol, 8, 67, 10.1016/S0924-977X(97)00079-5 Rogers, 1996, The efficacy and safety of donepezil in patients with Alzheimer's disease: results of a US multicenter, randomized, double-blind, placebocontrolled trial. The Donepezil Study Group, Dementia, 7, 293 Sano, 1997, A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease, N Engl J Med., 336, 1216, 10.1056/NEJM199704243361704 Taragano, 1997, A double-blind, randomized, fixed-dose trial of fluoxetine vs amitriptyline in the treatment of major depression complicating Alzheimer's disease, Psychosomatics, 38, 246, 10.1016/S0033-3182(97)71461-0 Tariot, 2000, A 5-month, randomized, placebo-controlled trial of galantamine in AD, Neurology, 54, 2269, 10.1212/WNL.54.12.2269 Wilcock, 2000, Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicenter randomized controlled trial, Br Med J, 32, 1